The aim of this study was to investigate the role of inflammation and atherothrombosis in Bell’s palsy (BP) by using neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV), respectively, and to study their relations with the facial nerve enhancement on temporal gadolinium-enhanced magnetic resonance imaging (TGd-MRI).
Study Design
Case control study.
Setting
Tertiary health institution.
Subjects and Methods
This study was performed on 65 patients who were diagnosed with BP and a control group of 35 healthy individuals. The BP patients were also divided into 2 groups, those with facial nerve enhancement on TGd-MRI and those without enhancement. The NLR and MPV of each group were compared.
Results
The NLRs of the BP patients were significantly higher than control group (P = .001). The NLRs of patients with facial nerve enhancement on TGd-MRI were significantly higher than patients without enhancement (P = .001). There was a positive and significant correlation between NLR and House-Brackmann (HB) grade of the patients (r = 0.641; P < .05). MPV did not show any significant correlation with any of the parameters studied (P > .05).
Conclusion
NLR can be used as a new and important marker in BP since it is high in BP patients and significantly correlated with HB grade and facial nerve enhancement on TGd-MR. On the other hand, MPV does not have such correlations. These results offer evidence to support an inflammatory theory rather than microvascular response theory in the etiopatogenesis of BP.
PeitersenE. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4-30.
2.
McGovernFHEstevezJJacksonR. Immunological concept for Bell’s palsy: further experimental study. Ann Otol Rhinol Laryngol. 1977;86:300-305.
3.
McCormickDP. Herpes-simplex virus as a cause of Bell’s palsy. Lancet. 1972;1:937-939.
4.
OmoriHIkedaMKukimotoNKawamotoHIkuiATomitaH. Activation of intravascular coagulation in Bell’s palsy. Eur Arch Otorhinolaryngol. 1994:471-472.
5.
OmoriHIkedaM. Intravascular hypercoagulability in patients with recent Bell’s palsy. Eur Arch Otorhinolaryngol. 1994;251:278-282.
6.
AhmedA. When is facial paralysis Bell palsy? Current diagnosis and treatment. Cleve Clin J Med. 2005;72:398-401, 405.
7.
SongMHKimJJeonJH. Clinical significance of quantitative analysis of facial nerve enhancement on MRI in Bell’s palsy. Acta Otolaryngol. 2008;128:1259-1265.
8.
SittelCStennertE. Prognostic value of electromyography in acute peripheral facial nerve palsy. Otol Neurotol. 2001;22:100-104.
9.
PiercyJ. Bell’s palsy. BMJ. 2005;330:1374.
10.
BaughRFBasuraGJIshiiLE. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg. 2013;149:1-27.
11.
HongHSYiBHChaJG. Enhancement pattern of the normal facial nerve at 3.0 T temporal MRI. Br J Radiol. 2010;83:118-121.
RudigerABurckhardtOAHarpesPMullerSAFollathF. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med. 2006;24:451-454.
14.
UluSBucakAUluMS. Neutrophil-lymphocyte ratio as a new predictive and prognostic factor at the hearing loss of diabetic patients. Eur Arch Otorhinolaryngol. 2013;1-6.
15.
AhsenAUluMSYukselS. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36:1357-1362.
16.
OzkanBUysalOKDuranM. Relationship between mean platelet volume and atherosclerosis in young patients with ST elevation myocardial infarction. Angiology. 2013;64:371-374.
17.
MayMKleinSR. Differential diagnosis of facial nerve palsy. Otolaryngol Clin North Am. 1991;24:613-645.
18.
BirdTDNicolausA. Friedreich’s description of peripheral facial nerve paralysis in 1798. J Neurol Neurosurg Psychiatry. 1979;42:56-58.
19.
CawthorneT. The pathology and surgical treatment of Bell’s palsy. J Laryngol Otol. 1951;65:792-804.
20.
JongkeesLB. Treatment of Bell’s palsy. Neurology. 1957;7:697-702.
21.
FischUEsslenE. Total intratemporal exposure of the facial nerve. Pathologic findings in Bell’s palsy. Arch Otolaryngol. 1972;95:335-341.
22.
MurakamiSMizobuchiMNakashiroYDoiTHatoNYanagiharaN. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124:27-30.
23.
Sartoretti-ScheferSWichmannWValavanisA. Idiopathic, herpetic, and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. AJNR Am J Neuroradiol. 1994;15:479-485.
24.
TamhaneUUAnejaSMontgomeryDRogersEKEagleKAGurmHS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657.
25.
ParamanathanASaxenaAMorrisDL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol. 2014;23:31-39.
26.
SzkanderaJGergerALiegl-AtzwangerB. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2014;135:362-370.
27.
TurkmenKGuneyIYerlikayaFHTonbulHZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail. 2012;34:155-159.
28.
GasparyanAYAyvazyanLMikhailidisDPKitasGD. Mean platelet volume: a link between thrombosis and inflammation?Curr Pharm Des. 2011;17:47-58.
29.
GreiseneggerSEndlerGHsiehKTentschertSMannhalterCLalouschekW. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?Stroke. 2004;35:1688-1691.
30.
BucakAUluSOrucS. Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope. 2014;124:1678-1681.
31.
UluSUluMSBucakAAhsenAYucedagFAycicekA. Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2013;34:1400-1404.
32.
HaliloğluSCarliogluASahinerEKaraaslanYKosarA. Mean platelet volume in patients with fibromyalgia. Z Rheumatol. 2014;1-4.
33.
GunluogluGYazarEEVeskeNSSeyhanECAltinS. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis. Multidiscip Respir Med. 2014;9:11.
34.
MaHLinHHuY. Mean platelet volume in relation to carotid atherosclerosis in normotensive, euglycemic, and normolipidemic chinese middle-aged and elderly adults. Angiology. 2014;65:512-518.
35.
KurisuSWatanabeNIkenagaH. Increased mean platelet volume in patients with coronary artery disease and its seasonal variation. Int J Cardiol. 2014;172:159-161.
36.
KarliRAlacamHUnalRKucukHAksoyAAyhanE. Mean platelet volume: is it a predictive parameter in the diagnosis of sudden sensorineural hearing loss?Indian J Otolaryngol Head Neck Surg. 2013;65:350-353.
37.
KangTSVrabecJTGiddingsNTerrisDJ. Facial nerve grading systems (1985-2002): beyond the House-Brackmann scale. Otol Neurotol. 2002;23:767-771.
38.
OzlerGSGunakG. Neutrophil-lymphocyte ratio: a new predictive and prognostic factor in patients with Bell palsy. J Craniofac Surg. 2014;25:944-945.
